Skip to main content
hello world

Closing Bell: Medexus Pharmaceuticals Inc up on Wednesday (MDP)

Automated Summaries - The Globe and Mail - Wed Jul 31, 4:02PM CDT

In trading today, Medexus Pharmaceuticals Inc shares closed at $2.41 after opening the day at $2.32. Intraday prices ranged from a low of $2.30 to a high of $2.42.

Share prices advanced 2.99 percent from the previous day's close of $2.34.

Today across North America, the TSX Composite closed 1.25% at 23110.81, the S&P 500 closed -0.50% at 5436.44, the Dow Jones Industrial Average closed 0.50% at 40743.33 and the Nasdaq Composite closed -1.28% at 17147.42.

Medexus Pharmaceuticals Inc traded under MDP on the Toronto Stock Exchange (TSX).

Trading volume was 9,624 on 29 total trades. On average, Medexus Pharmaceuticals Inc has traded 17,979 shares in the last five days and 48,956 year-to-date.

The TSX market on the whole today saw 3,418 price advancers against 1,773 declines and 138 unchanged.

During the prior 52 weeks, MDP.TO has traded as high as $3.53 (August 24,2023) and low as $1.44 (December 04,2023). Moreover, in the last 12 months, Medexus Pharmaceuticals Inc's shares have advanced 18.14%, while this year, they have shrunken -2.43%.

Following today's trading, Medexus Pharmaceuticals Inc has a market capitalization of $57.23 million on a float of 24,459 shares outstanding. Its annual EPS is $-0.01.

Medexus Pharmaceuticals Inc is a TSX Drug Specialty & Generic company headquartered in Toronto, CAN.

Medexus Pharmaceuticals Inc is holding an average recommendation of "Moderate Buy" from 4.00 analysts according to Zacks. Currently, there are 3 buy ratings and 1 hold ratings for the stock.

AI at The Globe and Mail
This report is produced using automated technology that summarizes market data into articles for our readers. Ongoing project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities..